EarningsNAVANAPHAR
NAVANAPHAR Earnings Update
Announcement summary
- What happened
- NAVANAPHAR published a corporate disclosure on 14 November 2022. Read the full announcement for details.
- Company
- Navana Pharmaceuticals PLC
- Announcement published
Original announcement
(Q1 Un-audited): EPS was Tk. 0.91 for July-September 2022 as against Tk. 0.76 for July-September 2021. NOCFPS was Tk. 1.18 for July-September 2022 as against Tk. 0.76 for July-September 2021. NAV per share was Tk. 46.91 as on September 30, 2022 and Tk. 43.41 as on June 30, 2022. Reasons for deviation in EPS and NOCFFPS: EPS has increased due to increase in sales revenue and efficient usages of material as well as reduced corporate tax rate for the period. (cont.)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6371b2f1b2c2584194721a75
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from NAVANAPHAR
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.